Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations

Human epidermal growth factor receptor 2 (HER2) plays an important role in the pathogenesis of various cancers. HER2 alterations have been suggested to be a therapeutic target in non‐small‐cell lung cancer (NSCLC), just as in breast and gastric cancers. We previously reported that the pan‐HER inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Torigoe, Hidejiro, Shien, Kazuhiko, Takeda, Tatsuaki, Yoshioka, Takahiro, Namba, Kei, Sato, Hiroki, Suzawa, Ken, Yamamoto, Hiromasa, Soh, Junichi, Sakaguchi, Masakiyo, Tomida, Shuta, Tsukuda, Kazunori, Miyoshi, Shinichiro, Toyooka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980184/
https://www.ncbi.nlm.nih.gov/pubmed/29532558
http://dx.doi.org/10.1111/cas.13571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980184/
https://www.ncbi.nlm.nih.gov/pubmed/29532558
http://dx.doi.org/10.1111/cas.13571

Ejemplares similares